Brett P. Monia, Chief Executive Officer at IONIS PHARMACEUTICALS INC (IONS), sold 77,686 shares at $31.65 ($2.5M) on 2025-02-04, disclosed to the SEC on 2025-02-06.
Scheduled sale ($2.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.65 | 38,843 | $1.2M | 50.0% |
| 2 | $31.65 | 38,843 | $1.2M | 50.0% |
| Total | $31.65 avg | 77,686 | $2.5M | 100% |
| Filing → |
| IONS | SELL | 2026-03-11 | $24.2M | — | Filing → |
| IONS | SELL | 2026-02-10 | $2.5M | — | Filing → |
| IONS | SELL | 2026-02-02 | $5.2M | — | Filing → |